NewGen BioPharma Corp. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/249858f5-0972-4852-8216-eaff8709bd04/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2014 | $0 | 2013-02-25 – 2014-07-31 | evidence 0001557240-14-000512 |
| FY 2013 | $0 | 2010-02-25 – 2014-04-30 | evidence 0001557240-14-000330 |
| FY 2012 | $0 | 2010-02-25 – 2013-04-30 | evidence 0001165527-13-000591 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NewGen BioPharma Corp. — all facts · Net Income · Operating Income